Leading with Purpose. Building for Impact.

Phlow’s Leadership

A Team Committed to Creating the Future of How Medicines Are Made.

At Phlow, leadership is driven by more than expertise; it’s guided by purpose. Our executive team, board of directors, and business advisors bring together deep knowledge in science, policy, innovation, and manufacturing, united by a shared mission to transform how medicines are developed and manufactured in America.

With every step forward, they’re advancing a new standard for pharmaceutical manufacturing — one that’s smarter, faster, more sustainable, and rooted in public good.

Executive Leadership.

Phlow’s team has unmatched experience in research, development, and commercialization of API, pharmaceuticals, and medical device products. In addition to having a deep understanding of the challenges associated with building complex products using new technology and advanced manufacturing facilities, we also recognize that quality, efficiency, and affordability of medicines is paramount to a stable healthcare system.

Eric S. Edwards, M.D., Ph.D.
CEO

Dan Hackman
PRESIDENT
Dave Ryan
CHIEF FINANCIAL OFFICER
Elizabeth Anne Whalley, R.N., M.B.A., J.D.
CHIEF LEGAL AND COMPLIANCE OFFICER
Robby Demeria
Chief Corporate Affairs Officer
Andrew Carpenter, Ph.D.
Chief Scientific Officer
Christopher Rogers
Chief Commercial Officer
Valerie Jewett
EVP Government Affairs
Juan Piacquadio
Chief Information Officer
Samantha H. Brock
VP Quality and Regulatory
Matt Fitzgerald
VP Operations and Engineering
Nathan Richards
VP FINANCE
Simon Hickling
VP CDMO Business Development

Strategic Leadership.

Phlow’s Board of Directors and Business Advisory Board play a critical role in shaping the future of how medicines are made. As trusted advisors and proven experts in fields ranging from contract development and manufacturing to policy, regulatory science, continuous flow chemistry, and cybersecurity, they help guide our most important decisions.

Together, these leaders also bring a broad spectrum of experience — from expanding access to life-saving medicines for HIV/AIDS, malaria, and tuberculosis globally, to driving down the cost of high-cost generics in the U.S. Their insight fuels our mission and ensures Phlow stays ahead of what’s next.

Board of Directors

Tim Mayleben
Chairman

Eric S. Edwards, M.D., Ph.D.
CEO and Co-founder, Phlow

Rosemary Gibson
Strategic Advisor
Guy Villax
Strategic Advisor
Thomas O’Malley, Jr.
Strategic Advisor
Melinda Hancock
Strategic Advisor
Anna Nekoranec
Strategic Advisor

Business advisory Board

General Gustave F. Perna
Former COO for Operation Warp Speed & Retired Four-Star General for the United States Army
Steve Klosk
Former CEO of Cambrex
Kerry Ingalls
Former COO of Poseida Therapeutics, Inc. and former Captain in the United States Navy
Joseph Warchol
Chief Financial Officer at North America Curium Pharma and former Chief Financial Officer at AMPAC/SK pharmteco
Joe Smith
Chief Scientific Officer at BD
Salvatore Guccione
Managing Director at Vasto Advisors
Carlo De Notaristefani
Former President & CEO, Global Operations at Teva Pharmaceutical Industries Ltd.